Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 450 publications

CYP450 activity, drug interactions and genetic polymorphisms: clinical relevance for the new selective cardiac myosin inhibitors.

CYP450 activity, drug interactions and genetic polymorphisms: clinical relevance for the new selective cardiac myosin inhibitors.

Journal: Expert opinion on drug safety
Published: November 28, 2025

Cryo-EM Reveals How Cardiomyopathy Therapeutic Drugs Modulate the Myosin Motors of the Heart.

Cryo-EM Reveals How Cardiomyopathy Therapeutic Drugs Modulate the Myosin Motors of the Heart.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

ALPK3 Cardiomyopathy: Integrative Review With Systematic Variant Curation, Mechanisms, and Translation.

ALPK3 Cardiomyopathy: Integrative Review With Systematic Variant Curation, Mechanisms, and Translation.

Journal: Circulation. Genomic and precision medicine
Published: November 12, 2025

Myosin Inhibitors for the Treatment of Obstructive Hypertrophic Cardiomyopathy: A Canadian Perspective on a First-in-Class Therapy.

Myosin Inhibitors for the Treatment of Obstructive Hypertrophic Cardiomyopathy: A Canadian Perspective on a First-in-Class Therapy.

Journal: Canadian journal of physiology and pharmacology
Published: November 12, 2025

Mavacamten Monotherapy in Real-World Patients with Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCM.

Mavacamten Monotherapy in Real-World Patients with Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCM.

Journal: Circulation. Genomic and precision medicine
Published: November 10, 2025

Myosin inhibition partially rescues the myofibre proteome in X-linked myotubular myopathy.

Myosin inhibition partially rescues the myofibre proteome in X-linked myotubular myopathy.

Journal: JCI insight
Published: November 06, 2025

Editorial: Hypertrophic Cardiomyopathy and Precision Medicine in Cardiovascular Disease.

Editorial: Hypertrophic Cardiomyopathy and Precision Medicine in Cardiovascular Disease.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 01, 2025

Characteristics and Outcomes of Mavacamten Use in 2440 Patients With Obstructive Hypertrophic Cardiomyopathy.

Characteristics and Outcomes of Mavacamten Use in 2440 Patients With Obstructive Hypertrophic Cardiomyopathy.

Journal: Journal of the American Heart Association
Published: October 28, 2025

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Targeting Sarcomeric Hypercontractility with Demonstrated Long-Term Safety and Efficacy-A Narrative Review.

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Targeting Sarcomeric Hypercontractility with Demonstrated Long-Term Safety and Efficacy-A Narrative Review.

Journal: Journal of clinical medicine
Published: October 22, 2025

Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy.

Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy.

Journal: Circulation
Published: October 20, 2025

Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy.

Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy.

Journal: Circulation
Published: October 20, 2025

ODYSSEY-HCM trial (Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy).

ODYSSEY-HCM trial (Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy).

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: October 07, 2025
Showing 1-12 of 450

Last Updated: 01/07/2026